Jan Regnström

3.0k total citations · 2 hit papers
29 papers, 2.4k citations indexed

About

Jan Regnström is a scholar working on Biochemistry, Surgery and Nutrition and Dietetics. According to data from OpenAlex, Jan Regnström has authored 29 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biochemistry, 11 papers in Surgery and 6 papers in Nutrition and Dietetics. Recurrent topics in Jan Regnström's work include Antioxidant Activity and Oxidative Stress (12 papers), Lipoproteins and Cardiovascular Health (6 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). Jan Regnström is often cited by papers focused on Antioxidant Activity and Oxidative Stress (12 papers), Lipoproteins and Cardiovascular Health (6 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). Jan Regnström collaborates with scholars based in Sweden, United States and Netherlands. Jan Regnström's co-authors include Jan Nilsson, Anders Hamsten, Prediman K. Shah, Anna Hultgårdh‐Nilsson, Per Tornvall, Christian Landou, Bojan Cercek, Edmund Falk, Antonio Fernández‐Ortíz and Juan J. Badimón and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Jan Regnström

28 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.

1995 575 citations Prediman K. Shah, Jan Regnström et al. PubMed profile →
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

1992 502 citations Jan Regnström, Jan Nilsson et al. The Lancet profile →

Peers

Countries citing papers authored by Jan Regnström

Since Specialization

Citations

This map shows the geographic impact of Jan Regnström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Regnström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Regnström more than expected).

Fields of papers citing papers by Jan Regnström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Regnström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Regnström. The network helps show where Jan Regnström may publish in the future.

Co-authorship network of co-authors of Jan Regnström

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Regnström. A scholar is included among the top collaborators of Jan Regnström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Regnström. Jan Regnström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient‐reported, observer‐reported and performance outcomes in qualification procedures at the European Medicines Agency 2013–2018 2023 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), Thorsten Vetter, Jan Regnström, Maria Tome, (unknown), Francesca Cerreta, Elmer Schabel, Spiros Vamvakas	2
2	Marketing authorisation of orphan medicines in Europe from 2000 to 2013 2017 ·Drug Discovery Today ·Matthias P. Hofer, (unknown), Maria Mavris, Franz Koenig, Thorsten Vetter, Martin Posch, Spiros Vamvakas, Jan Regnström, (unknown)	24
3	Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency 2014 ·Trials ·Amelie Elsäßer, Jan Regnström, Thorsten Vetter, Franz Koenig, Robert Hemmings, (unknown), Marisa Papaluca‐Amati, Martin Posch	55
4	Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency 2009 ·European Journal of Clinical Pharmacology ·Jan Regnström, Franz Koenig, B. Aronsson, (unknown), Kristian Svendsen, Stelios Tsigkos, Bruno Flamion, Hans‐Georg Eichler, Spiros Vamvakas	83
5	In vitro and in vivo lipolysis of plasma triglycerides increases the resistance to oxidative modification of low‐density lipoproteins 2003 ·European Journal of Clinical Investigation ·Camilla Skoglund-Andersson, Fredrik Karpe, Mai-Lis Hellénius, Jan Regnström, Anders Hamsten, Per Tornvall	4
6	Phosphatase activity in the arterial wall after balloon injury: effect of somatostatin analog octreotide. 1999 ·PubMed ·Makoto Yamashita, Paul C. Dimayuga, Sanjay Kaul, (unknown), Jan Regnström, Johanna Nilsson, Bojan Cercek	16
7	Serum urate determines antioxidant capacity in middle‐aged men – a controlled, randomized diet and exercise intervention study 1999 ·Journal of Internal Medicine ·Magdalena Rosell, Jan Regnström, Anders Kallner, Mai-Lis Hellénius	26
8	Immunization With Homologous Oxidized Low Density Lipoprotein Reduces Neointimal Formation After Balloon Injury in Hypercholesterolemic Rabbits 1997 ·Journal of the American College of Cardiology ·Jan Nilsson, Federico Calara, Jan Regnström, Anna Hultgårdh‐Nilsson, Sean Ameli, Bojan Cercek, Prediman K. Shah	88
9	A Decrease in Cardiovascular Risk Factors in Healthy 40-year-old Swedish Men between 1980-1983 and 1991-1992 1996 ·European Journal of Cardiovascular Prevention & Rehabilitation ·Per Tornvall, Peter Båvenholm, Mai-Lis Hellénius, Fredrik Karpe, Jan Regnström, Ulf dé Fairé	5
10	Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease 1996 ·American Journal of Clinical Nutrition ·Jan Regnström, Jan Nilsson, Peter Moldéus, Kerstin Ström, Peter Båvenholm, Per Tornvall, Anders Hamsten	47
11	The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis 1996 ·Atherosclerosis ·Jan Regnström, Göran Walldius, Sven Nilsson, Liselotte Schäfer Elinder, Jan Johansson, Jörgen Mölgaard, Ingar Holme, Anders Olsson, Jan Nilsson	23
12	Active Oxygen Species and Lysophosphatidylcholine Are Involved in Oxidized Low Density Lipoprotein Activation of Smooth Muscle Cell DNA Synthesis 1996 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ann Stiko, Jan Regnström, Prediman K. Shah, Bojan Cercek, Jan Nilsson	74
13	The Susceptibility of Low Density Lipoprotein to Chemical Oxidation is Closely Related to Proneness to Biological Modification 1995 ·Free Radical Research ·Johan Frostegård, Jan Regnström, Per Tornvall, Anders Hamsten, Jan Nilsson	3
14	Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoprotein 1994 ·Atherosclerosis ·Jan Regnström, Göran Walldius, Karin Hådell, Jan Johansson, Ingar Holme, Anders Olsson, Jan Nilsson	6
15	The role of lipids and antioxidative factors for development of atherosclerosis 1993 ·The American Journal of Cardiology ·Göran Walldius, Jan Regnström, Jan Nilsson, Jan Johansson, Liselotte Schäfer Elinder, (unknown), Karin Hådell, Anders Olsson, Lars A. Carlson	27
16	Analysis of Lipoprotein Diene Formation in Human Serum Exposed to Copper 1993 ·Free Radical Research Communications ·Jan Regnström, Kerstin Ström, Peter Moldéus, (unknown)	76
17	Lipid oxidation and atherosclerosis. 1992 ·PubMed ·Jan Nilsson, Jan Regnström, Johan Frostegård, Ann Stiko	12
18	Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man breakdown → 1992 ·The Lancet ·Jan Regnström, Jan Nilsson, Per Tornvall, Anders Hamsten, Christian Landou	502
19	Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. 1992 ·Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·(unknown), Anna Hultgårdh‐Nilsson, Jan Regnström, Anders Hamsten, Jan Nilsson	146
20	Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro 1990 ·Atherosclerosis ·Jan Regnström, Göran Walldius, Lars A. Carlson, Josefin Nilsson	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact